PRLD
Prelude Therapeutics IncCompany with tickers: PRLD
CIK
1678660
CUSIP
74065P101
Shares Outstanding
64,917,172
13F Activity (30d)
55 filings
54 filers
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-05-01 | Morris Charles Q | Chief Medical Officer | Award | 450,000 |
| 2026-04-27 | RA CAPITAL MANAGEMENT, L.P. | Director | Other | 1,407,000 |
| 2026-04-27 | RA CAPITAL MANAGEMENT, L.P. | Director | Other | 1,407,000 |
| 2026-04-21 | Bonita David P | Director, 10% Owner | Other | 526,300 |
| 2026-04-21 | Bonita David P | Director, 10% Owner | Buy | 1,126,126 |
| 2026-04-21 | Bonita David P | Director, 10% Owner | Buy | 1,689,189 |
| 2026-04-21 | ORBIMED ADVISORS LLC | 10% Owner | Other | 526,300 |
| 2026-04-21 | ORBIMED ADVISORS LLC | 10% Owner | Buy | 1,126,126 |
| 2026-04-21 | ORBIMED ADVISORS LLC | 10% Owner | Buy | 1,689,189 |
| 2026-04-21 | BAKER BROS. ADVISORS LP | Director, 10% Owner | Buy | 2,137,651 |
| 2026-04-21 | BAKER BROS. ADVISORS LP | Director, 10% Owner | Buy | 114,601 |
| 2026-04-21 | RA CAPITAL MANAGEMENT, L.P. | Director | Other | 7,882,882 |
| 2026-04-15 | Morris Charles Q | Chief Medical Officer | Other | 0 |
| 2026-03-05 | Brusky Sean P. | Chief Business Officer | Other | 0 |
| 2026-03-05 | Brusky Sean P. | Chief Business Officer | Other | 0 |
| 2026-03-05 | Brusky Sean P. | Chief Business Officer | Other | 100,000 |
| 2026-03-05 | Brusky Sean P. | Chief Business Officer | Other | 0 |
| 2026-02-04 | Lim Bryant David | CLO, CFO, Corp Sec. | Award | 275,000 |
| 2026-02-04 | Vaddi Krishna | Director, CEO | Award | 837,000 |
| 2026-02-04 | Combs Andrew | Chief Chemistry Officer | Award | 230,000 |
| 2026-02-04 | Scherle Peggy | Chief Scientific Officer | Award | 230,000 |
| 2025-11-05 | Sandor Victor | Director | Award | 121,285 |
| 2025-10-17 | Dorton Katina | Director | Award | 76,000 |
| 2025-10-17 | Dorton Katina | Director | Other | 0 |
| 2025-10-04 | Huang Jane | CMO, Hematology | Convert | 9,375 |
| 2025-10-04 | Huang Jane | CMO, Hematology | Tax | 3,355 |
| 2025-10-04 | Huang Jane | CMO, Hematology | Convert | 9,375 |
| 2025-07-04 | Huang Jane | CMO, Hematology | Convert | 9,375 |
| 2025-07-04 | Huang Jane | CMO, Hematology | Convert | 9,375 |
| 2025-07-04 | Huang Jane | CMO, Hematology | Tax | 3,355 |
| 2025-06-12 | FRIEDMAN PAUL A | Director | Award | 38,000 |
| 2025-06-12 | Bonita David P | Director, 10% Owner | Award | 38,000 |
| 2025-06-12 | Babler Martin | Director | Award | 38,000 |
| 2025-06-12 | BAKER BROS. ADVISORS LP | Director, 10% Owner | Award | 76,000 |
| 2025-06-12 | BAKER BROS. ADVISORS LP | Director, 10% Owner | Award | 76,000 |
| 2025-06-12 | Sandor Victor | Director | Award | 38,000 |
| 2025-06-12 | Dier Mardi | Director | Award | 38,000 |
| 2025-06-12 | Scherer Paul C | Director | Other | 0 |
| 2025-04-04 | Huang Jane | CMO, Hematology | Tax | 3,355 |
| 2025-04-04 | Huang Jane | CMO, Hematology | Convert | 9,375 |
| 2025-04-04 | Huang Jane | CMO, Hematology | Convert | 9,375 |
| 2025-03-25 | Combs Andrew | Chief Chemistry Officer | Buy | 100,000 |
| 2025-03-25 | Vaddi Krishna | Director, CEO | Other | 551,774 |
| 2025-03-25 | Vaddi Krishna | Director, CEO | Other | 142,553 |
| 2025-03-25 | Vaddi Krishna | Director, CEO | Buy | 675,000 |
| 2025-03-25 | Vaddi Krishna | Director, CEO | Other | 551,776 |
| 2025-03-25 | Vaddi Krishna | Director, CEO | Other | 423,655 |
| 2025-03-21 | Vaddi Krishna | Director, CEO | Buy | 15,000 |
| 2025-03-20 | Vaddi Krishna | Director, CEO | Other | 423,655 |
| 2025-03-20 | Vaddi Krishna | Director, CEO | Other | 142,553 |
| 2025-03-20 | Vaddi Krishna | Director, CEO | Other | 551,776 |
| 2025-03-20 | Vaddi Krishna | Director, CEO | Other | 551,774 |
| 2025-03-20 | Vaddi Krishna | Director, CEO | Buy | 5,416 |
| 2025-03-17 | Vaddi Krishna | Director, CEO | Buy | 9,106 |
| 2025-03-14 | Vaddi Krishna | Director, CEO | Other | 423,655 |
| 2025-03-14 | Vaddi Krishna | Director, CEO | Other | 551,774 |
| 2025-03-14 | Vaddi Krishna | Director, CEO | Other | 551,776 |
| 2025-03-14 | Vaddi Krishna | Director, CEO | Other | 142,553 |
| 2025-03-14 | Vaddi Krishna | Director, CEO | Buy | 29,999 |
| 2025-03-13 | Vaddi Krishna | Director, CEO | Buy | 50,000 |
| 2025-03-12 | Vaddi Krishna | Director, CEO | Other | 142,553 |
| 2025-03-12 | Vaddi Krishna | Director, CEO | Other | 551,774 |
| 2025-03-12 | Vaddi Krishna | Director, CEO | Other | 423,655 |
| 2025-03-12 | Vaddi Krishna | Director, CEO | Buy | 47,500 |
| 2025-03-12 | Vaddi Krishna | Director, CEO | Other | 551,776 |
| 2025-02-04 | Lim Bryant David | CLO, CFO, Corp Sec. | Award | 200,000 |
| 2025-02-04 | Scherle Peggy | Chief Scientific Officer | Award | 175,000 |
| 2025-02-04 | Combs Andrew | Chief Chemistry Officer | Award | 175,000 |
| 2025-02-04 | Huang Jane | CMO, Hematology | Award | 200,000 |
| 2025-02-04 | Vaddi Krishna | Director, CEO | Award | 496,000 |
| 2025-01-04 | Huang Jane | CMO, Hematology | Convert | 9,375 |
| 2025-01-04 | Huang Jane | CMO, Hematology | Convert | 9,375 |
| 2025-01-04 | Huang Jane | CMO, Hematology | Tax | 3,859 |
| 2024-12-31 | Vaddi Krishna | Director, CEO | Other | 1,167,275 |
| 2024-12-31 | Vaddi Krishna | Director, CEO | Other | 551,776 |
| 2024-12-31 | Vaddi Krishna | Director, CEO | Buy | 5,000 |
| 2024-12-31 | Vaddi Krishna | Director, CEO | Other | 551,774 |
| 2024-12-31 | Vaddi Krishna | Director, CEO | Other | 423,655 |
| 2024-12-30 | Vaddi Krishna | Director, CEO | Other | 1,167,275 |
| 2024-12-30 | Vaddi Krishna | Director, CEO | Other | 423,665 |
| 2024-12-30 | Vaddi Krishna | Director, CEO | Buy | 10,000 |
| 2024-12-30 | Vaddi Krishna | Director, CEO | Other | 551,776 |
| 2024-12-30 | Vaddi Krishna | Director, CEO | Other | 551,774 |
| 2024-12-23 | Combs Andrew | Chief Chemistry Officer | Buy | 60,000 |
| 2024-12-20 | Combs Andrew | Chief Chemistry Officer | Buy | 3,075 |
| 2024-12-19 | Lim Bryant David | CLO, CFO, Corp Sec. | Buy | 25,000 |
| 2024-12-19 | Vaddi Krishna | Director, CEO | Buy | 6,888 |
| 2024-12-18 | Vaddi Krishna | Director, CEO | Other | 551,774 |
| 2024-12-18 | Vaddi Krishna | Director, CEO | Other | 423,665 |
| 2024-12-18 | Vaddi Krishna | Director, CEO | Other | 551,776 |
| 2024-12-18 | Vaddi Krishna | Director, CEO | Buy | 100,000 |
| 2024-10-04 | Huang Jane | CMO, Hematology | Convert | 9,375 |
| 2024-10-04 | Huang Jane | CMO, Hematology | Tax | 3,349 |
| 2024-10-04 | Huang Jane | CMO, Hematology | Convert | 9,375 |
| 2024-07-04 | Huang Jane | CMO, Hematology | Tax | 3,347 |
| 2024-07-04 | Huang Jane | CMO, Hematology | Convert | 9,375 |
| 2024-07-04 | Huang Jane | CMO, Hematology | Convert | 9,375 |
| 2024-06-14 | BAKER BROS. ADVISORS LP | Director, 10% Owner | Award | 23,500 |
| 2024-06-14 | BAKER BROS. ADVISORS LP | Director, 10% Owner | Award | 23,500 |
| 2024-06-14 | Sandor Victor | Director | Award | 23,500 |